Company profile

GSK stock data

(
)

Calendar

6 Mar 20
24 Nov 20

News

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
24 Jul 20 GlaxoSmithKline Common Stock Buy Aquire P No 2.25 1,260,504 2.84M 4,626,389
24 Jul 20 GlaxoSmithKline Warrant Common Stock Buy Aquire P No 0.125 1,260,504 157.56K 1,260,504
21 Jul 20 GlaxoSmithKline Common Stock Buy Aquire P No 18 361,111 6.5M 2,248,304
21 Jul 20 GlaxoSmithKline Common Stock Conversion Aquire C No 0 348,469 0 1,887,193
21 Jul 20 GlaxoSmithKline Common Stock Conversion Aquire C No 0 1,538,724 0 1,538,724
21 Jul 20 GlaxoSmithKline Series B Preferred Stock Common Stock Conversion Dispose C No 0 1,776,980 0 0
21 Jul 20 GlaxoSmithKline Series A Preferred Stock Common Stock Conversion Dispose C No 0 7,846,554 0 0
17 Jul 20 GlaxoSmithKline Stock Option Common Stock Grant Aquire A No 18 13,997 251.95K 13,997
15 Jul 20 GlaxoSmithKline Common Stock Sell Dispose S No 19.25 78 1.5K 1,910,531
15 Jul 20 GlaxoSmithKline Common Stock Sell Dispose S No 19.4016 3,069 59.54K 1,910,609
11.9% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 784 808 -3.0%
Opened positions 72 88 -18.2%
Closed positions 96 71 +35.2%
Increased positions 230 258 -10.9%
Reduced positions 321 311 +3.2%
13F shares
Current Prev Q Change
Total value 11.13B 12.39B -10.2%
Total shares 295.99M 304.02M -2.6%
Total puts 1.79M 1.96M -8.4%
Total calls 1.95M 2.06M -5.3%
Total put/call ratio 0.9 1.0 -3.2%
Largest owners
Shares Value Change
Dodge & Cox 45M $1.69B +8.4%
FMR 19.76M $743.89M -1.0%
Renaissance Technologies 18.33M $689.93M -10.8%
N Price T Rowe Associates 17.69M $665.79M +0.4%
Capital International Investors 16.51M $621.19M -12.3%
Fisher Asset Management 16.23M $610.76M +2.2%
RY Royal Bank of Canada 15.56M $585.85M -7.2%
STT State Street 9.39M $357.91M +0.8%
Hotchkis & Wiley Capital Management 7.4M $278.71M +2.5%
Black Creek Investment Management 6.49M $244.13M +11.9%
Largest transactions
Shares Bought/sold Change
Dodge & Cox 45M +3.48M +8.4%
Camber Capital Management 450K -2.55M -85.0%
Capital International Investors 16.51M -2.32M -12.3%
Renaissance Technologies 18.33M -2.22M -10.8%
Two Sigma Investments 170.32K -1.38M -89.0%
Jane Street 1.39M +1.21M +673.7%
RY Royal Bank of Canada 15.56M -1.2M -7.2%
Ubs Global Asset Management Americas 83.3K -1.12M -93.1%
Connor, Clark & Lunn Investment Management 0 -808.17K EXIT
American Century Companies 2.84M +698.05K +32.5%
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: abnormal, accrual, actuarial, Additionally, adequacy, administering, agent, aim, alfa, alter, analyst, analytical, andAdvil, andBenlysta, andDovato, andMaxinutrition, area, arena, arisen, Artificial, assumption, avenue, belantamab, biggest, billing, bintrafusp, biography, biosimilar, branch, bribe, briefly, budgeting, bullet, buy, buying, buyout, byAugmentin, byTivicay, cap, CCL, chargeback, Chase, clawback, closer, closest, closure, column, Commodity, compel, complementary, compound, contradictory, corroborative, Council, country, coupled, CROIC, cumulative, Custodian, cyberattack, deficit, depreciation, describedin, difficulty, discontinued, dispute, dissemination, dostarlimab, easier, element, eliminating, EMA, embed, embedded, entirety, ESOP, EURIBOR, evasion, exact, ExcludingAdvair, explicitly, externalised, false, FCA, floating, formulary, forward, fragmented, frequency, GBP, genericAdvair, genericisation, globe, great, greatest, handling, harder, hazard, Hindustan, honoured, IASB, IFRIC, immune, Immunopharma, inBoostrix, includingLamictal, indemnification, Index, inFlonase, inJuluca, injury, instability, Intelligence, interrogation, inTheraflu, inTriumeq, invoice, invoiced, invoicing, IPO, IPTc, irrevocably, Jonathan, JPMorgan, judgement, KgaA, laboratory, lag, laundering, leader, LIBOR, longest, lowerCervarix, Lyell, Lynch, macro, mainland, match, matched, matching, Medicaid, Medicare, Merck, Merrill, methodology, monthly, Moody, Morgan, move, moving, negotiate, novation, ofChapStick, ofDovato, offence, ofPanadol, ofShingrix, ofTrelegy, ofTrelegyEllipta, ofViread, ofZejula, onAdvair, online, onTrelegy, optimise, OT, output, Overnight, pace, particularlyShingrix, passage, past, pattern, persuade, PF, picture, prescription, President, primarilyZejula, prioritise, privileged, program, Progyny, ratio, rationalisation, ready, Recalculated, Redburn, refinanced, reinforcing, reinvested, remote, repayable, reprioritisation, repurchased, retrospective, reversal, rheumatoid, sample, scale, serialisation, short, shortly, simply, situation, smooth, Society, SOFR, SONIA, speculative, speedy, standalone, Stanley, store, STR, substantive, successor, Suisse, suit, swap, swapped, SWIFT, TCO, theft, TMG, toBexsero, trail, ultimate, unavailability, unconditional, underway, undue, Unilever, unintended, uninterrupted, uplift, usage, USD, vendor, verified, Vice, vulnerable, welfare, window, withTriumeq, yearAdvair
Removed: accrue, adapt, administration, anaemia, andRotarix, andSensodyne, annum, API, Aspen, attempt, attributable, bearing, Bright, broader, capitalised, cGMP, consistency, controlled, corrupted, decreased, demonetisation, East, embodiment, EU, GMP, immunisation, Japan, John, label, mid, Middle, mission, momentum, Nigeria, obligated, overarching, Patrick, preclinical, predominantly, proactively, protecting, remedial, remediation, restriction, SE, Setfirst, Simon, sound, substitutable, supplier, surrendering, TheAvodart, thereon, Thompson, true, unwinding, Vallance, variant, whileAugmentin, winding

Proxies

No filings